BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 6862887)

  • 1. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dyskeratosis follicularis vegetans (Darier disease)--therapy with the aromatic retinoid RO 10-9359 (Tigason) in combination with systemic photochemotherapy (RePUVA)].
    Sönnichsen N; Brenke A; Diezel W
    Dermatol Monatsschr; 1982 Aug; 168(8):520-2. PubMed ID: 7173474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination aromatic retinoid-PUVA-therapy in the treatment of psoriatic arthritis. Preliminary study].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1979 Dec; 106(12):1037-8. PubMed ID: 533103
    [No Abstract]   [Full Text] [Related]  

  • 5. [New treatment of severe psoriasis-effects of the combination therapy of etretinate (Ro 10-9359) and PUVA or external corticoid (author's transl)].
    Sato A; Takahashi M; Seiji M
    Nihon Hifuka Gakkai Zasshi; 1981 Dec; 91(14):1803-15. PubMed ID: 6977667
    [No Abstract]   [Full Text] [Related]  

  • 6. Light and electron microscopy of psoriatic skin before and during retinoid (Ro 10-9359) and retinoid-PUVA treatment.
    Kanerva L; Lauharanta J; Niemi KM; Lassus A
    J Cutan Pathol; 1982 Jun; 9(3):175-88. PubMed ID: 7130503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retinoid PUVA (RePUVA): systemic combination therapy in psoriasis].
    Orfanos CE; Pullmann H; Sterry W; Künzig M
    Z Hautkr; 1978 Jul; 53(14):494-504. PubMed ID: 676424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
    Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis.
    Lauharanta J; Juvakoski T; Lassus A
    Br J Dermatol; 1981 Mar; 104(3):325-32. PubMed ID: 7011359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined treatment of severe forms of psoriasis using aromatic retinoid].
    Mashkilleĭson AL; Mashkilleĭson NA
    Vestn Dermatol Venerol; 1982 Sep; (9):42-5. PubMed ID: 7180191
    [No Abstract]   [Full Text] [Related]  

  • 11. [New aspects and developments in antipsoriasis retinoid therapy].
    Orfanos CE; Gollnick H; Tsambaos D
    Hautarzt; 1981 Jun; 32(6):275-80. PubMed ID: 7263232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine structure of the intercellular space of psoriatic epidermis during retinoid (RO 10-9359) and retinoid-PUVA treatment.
    Kanerva L; Lauharanta J; Niemi KM; Lassus A
    Acta Derm Venereol; 1981; 61(4):319-28. PubMed ID: 6173987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
    Rosenthal M
    Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
    Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
    Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason).
    Grupper C; Berretti B
    Dermatologica; 1981; 162(5):404-13. PubMed ID: 7250475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 1-year study in the use of aromatic retinoids and PUVA therapy in the treatment of psoriasis vulgaris].
    Dostanić I; Leković B
    Med Pregl; 1982; 35(7-8):279-82. PubMed ID: 7167122
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
    Rüst O; Tufli T
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.